Future directions and management of liquid biopsy in non-small cell lung cancer
Lung cancer represents the world's most common cause of cancer death. In recent years, we moved from a generic therapeutic strategy to a personalized approach, based on the molecular characterization of the tumor. In this view, liquid biopsy is becoming an important tool for assessing the progr...
Saved in:
Main Authors: | Alessia Maria Cossu (Author), Marianna Scrima (Author), Angela Lombardi (Author), Anna Grimaldi (Author), Margherita Russo (Author), Alessandro Ottaiano (Author), Michele Caraglia (Author), Marco Bocchetti (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm
by: Alessandro Ottaiano, et al.
Published: (2021) -
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
by: Sunhee Chang, et al.
Published: (2020) -
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer
by: Pasquale Pisapia, et al.
Published: (2021) -
Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
by: Umberto Malapelle, et al.
Published: (2021) -
Application of liquid biopsy in lung cancer management
by: Shraddhanjali Satapathy, et al.
Published: (2024)